The Molecular Biology of Myeloma

David S. Siegel, MD, PhD

Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
January 20, 2016

Pathways to a Cancer Stem Cell

Dr Wainberg expands upon what makes these types of cells unique.

September 20, 2013

Cost, Value and Access of Personalized Medicine

Linda Bosserman provides an overview of the nuances of personalized medicine as it relates to cost, value and access